This topic contains a solution. Click here to go to the answer

Author Question: What type of anemia results from a vitamin B12 or folic acid deficiency, or both? Hemolytic ... (Read 58 times)

dmcintosh

  • Hero Member
  • *****
  • Posts: 517
What type of anemia results from a vitamin B12 or folic acid deficiency, or both?
 
 Hemolytic
  Normochromic-normocytic
  Hypochromic-microcytic
  Macrocytic

Question 2

Generally, the ownership of medical records resides with
 
 the physician/clinic/hospital's legal representative
  the patient
  the physician/clinic/hospital and the patient jointly
  the physician/clinic/hospital



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lucas dlamini

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

Macrocytic

Rationale: A macrocytic anemia results from a vitamin B12 or folic acid deficiency.

Answer to Question 2

the physician/clinic/hospital

Rationale: Generally, ownership of the medical record resides with the person or organization generating the entries. Providers may own the records but patients own the information and are generally given access to that information.





 

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

If you could remove all of your skin, it would weigh up to 5 pounds.

Did you know?

To maintain good kidney function, you should drink at least 3 quarts of water daily. Water dilutes urine and helps prevent concentrations of salts and minerals that can lead to kidney stone formation. Chronic dehydration is a major contributor to the development of kidney stones.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

For a complete list of videos, visit our video library